Literature DB >> 14986167

Group B streptococcal disease in nonpregnant adults: incidence, clinical characteristics, and outcome.

D Blancas1, M Santin, M Olmo, F Alcaide, J Carratala, F Gudiol.   

Abstract

A retrospective review of 150 cases of group B streptococcal disease in nonpregnant adults over an 8-year period was performed in a single tertiary-care teaching hospital to determine the incidence, clinical spectrum, and outcome of the disease. Incidence increased from 0.53 cases per 1,000 admissions in the 1993-1994 period to 0.96 cases per 1,000 admissions in 1999-2000 (P=0.013, chi-square test for trend). Bacteremia also increased from 0.15 to 0.42 cases per 1,000 admissions over the same period of time (P=0.005, chi-square test for trend). The mean age of the patients was 61.4 years, and 92% had at least one underlying disease. Bacteremia was detected in 60.9% of patients in whom blood cultures were performed. Fourteen (9.3%) patients died. Factors independently associated with an increased risk of dying were shock at diagnosis (OR, 23.96; 95%CI, 3.44-166.57; P=0.001) and cancer (OR, 4.96; 95%CI, 1.43-17.20; P=0.012). Group B streptococcal disease in nonpregnant adults is on the rise in the hospital investigated, particularly in persons with underlying conditions. The clinical spectrum of the disease ranges from localized to severe bacteremic infections. Shock at diagnosis and cancer are factors independently associated with a higher fatality rate.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14986167     DOI: 10.1007/s10096-003-1098-9

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  20 in total

1.  Proposed modifications to the Duke criteria for the diagnosis of infective endocarditis.

Authors:  J S Li; D J Sexton; N Mick; R Nettles; V G Fowler; T Ryan; T Bashore; G R Corey
Journal:  Clin Infect Dis       Date:  2000-04-03       Impact factor: 9.079

2.  Group B streptococcal disease in the era of intrapartum antibiotic prophylaxis.

Authors:  S J Schrag; S Zywicki; M M Farley; A L Reingold; L H Harrison; L B Lefkowitz; J L Hadler; R Danila; P R Cieslak; A Schuchat
Journal:  N Engl J Med       Date:  2000-01-06       Impact factor: 91.245

Review 3.  Streptococcus agalactiae infective endocarditis: analysis of 30 cases and review of the literature, 1962-1998.

Authors:  A Sambola; J M Miro; M P Tornos; B Almirante; A Moreno-Torrico; M Gurgui; E Martinez; A Del Rio; M Azqueta; F Marco; J M Gatell
Journal:  Clin Infect Dis       Date:  2002-05-24       Impact factor: 9.079

Review 4.  [Endocarditis caused by group B streptococci in adults].

Authors:  A Marron; J Carratalà; C Peña; B Rosón; F Tubau; G Rufí
Journal:  Enferm Infecc Microbiol Clin       Date:  1997-03       Impact factor: 1.731

5.  Serotyping and antimicrobial susceptibility of group B Streptococcus over an eight-year period in southern Taiwan.

Authors:  W C Ko; H C Lee; L R Wang; C T Lee; A J Liu; J J Wu
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2001-05       Impact factor: 3.267

6.  Group B streptococcus bacteremia in nonpregnant adults.

Authors:  P Muñoz; A Llancaqueo; M Rodríguez-Créixems; T Peláez; L Martin; E Bouza
Journal:  Arch Intern Med       Date:  1997-01-27

Review 7.  Group B streptococcus (Streptococcus agalactiae) pyogenic arthritis in nonpregnant adults.

Authors:  Joan M Nolla; Carmen Gómez-Vaquero; Xavier Corbella; Sergi Ordóñez; Carmen García-Gómez; Albert Pérez; Javier Cabo; Josep Valverde; Javier Ariza
Journal:  Medicine (Baltimore)       Date:  2003-03       Impact factor: 1.889

8.  Group B streptococcal bacteraemia in the elderly.

Authors:  C Trivalle; E Martin; P Martel; B Jacque; J F Menard; J F Lemeland
Journal:  J Med Microbiol       Date:  1998-07       Impact factor: 2.472

9.  Invasive group B streptococcal disease: the emergence of serotype V.

Authors:  H M Blumberg; D S Stephens; M Modansky; M Erwin; J Elliot; R R Facklam; A Schuchat; W Baughman; M M Farley
Journal:  J Infect Dis       Date:  1996-02       Impact factor: 5.226

Review 10.  Group B streptococcal bacteremia in adults. Five years' experience and a review of the literature.

Authors:  J M Colford; J Mohle-Boetani; K L Vosti
Journal:  Medicine (Baltimore)       Date:  1995-07       Impact factor: 1.889

View more
  33 in total

Review 1.  Interaction of neonatal phagocytes with group B streptococcus: recognition and response.

Authors:  Philipp Henneke; Reinhard Berner
Journal:  Infect Immun       Date:  2006-06       Impact factor: 3.441

2.  Identification of a Streptococcus agalactiae serotype III subtype 4 clone in association with adult invasive disease in Hong Kong.

Authors:  Margaret Ip; Edmund S C Cheuk; Michelle H Y Tsui; Fanrong Kong; T N Leung; Gwendolyn L Gilbert
Journal:  J Clin Microbiol       Date:  2006-09-27       Impact factor: 5.948

3.  Characterisation of invasive group B streptococci from adults in Denmark 1999 to 2004.

Authors:  L Lambertsen; K Ekelund; I C Skovsted; A Liboriussen; H-C Slotved
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2010-07-31       Impact factor: 3.267

4.  An "aubergine" in the heart: huge native mitral valve endocarditis caused by Streptococcus agalactiae.

Authors:  Salvatore Amico; Luigi Calvo; Salvatore Corrao
Journal:  Intern Emerg Med       Date:  2017-08-16       Impact factor: 3.397

5.  Characterization of invasive and colonizing isolates of Streptococcus agalactiae in East African adults.

Authors:  Charlotte A Huber; Francis McOdimba; Valentin Pflueger; Claudia A Daubenberger; Gunturu Revathi
Journal:  J Clin Microbiol       Date:  2011-08-24       Impact factor: 5.948

6.  Molecular characterization and prophage DNA contents of Streptococcus agalactiae strains isolated from adult skin and osteoarticular infections.

Authors:  Mazen Salloum; Nathalie van der Mee-Marquet; Anne-Sophie Domelier; Laurence Arnault; Roland Quentin
Journal:  J Clin Microbiol       Date:  2010-02-24       Impact factor: 5.948

Review 7.  Group B Streptococcus vaccine: state of the art.

Authors:  Annalisa Nuccitelli; C Daniela Rinaudo; Domenico Maione
Journal:  Ther Adv Vaccines       Date:  2015-05

8.  N-acetylcysteine improves group B streptococcus clearance in a rat model of chronic ethanol ingestion.

Authors:  Sonja M Tang; Levan Gabelaia; Theresa W Gauthier; Lou Ann S Brown
Journal:  Alcohol Clin Exp Res       Date:  2009-04-09       Impact factor: 3.455

9.  Streptococcus agalactiae infection in cancer patients: a five-year study.

Authors:  B A S Pimentel; C A S Martins; J C Mendonça; P S D Miranda; G F Sanches; A L Mattos-Guaraldi; P E Nagao
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2016-03-18       Impact factor: 3.267

10.  Abundance of the delta subunit of RNA polymerase is linked to the virulence of Streptococcus agalactiae.

Authors:  Ravin Seepersaud; Rachel H V Needham; Cathy S Kim; Amanda L Jones
Journal:  J Bacteriol       Date:  2006-03       Impact factor: 3.490

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.